Davies M C, Anderson M C, Mason B A, Jacobs H S
Department of Reproductive Endocrinology, Cobbold Laboratories, University College and Middlesex School of Medicine, London, UK.
Hum Reprod. 1990 Oct;5(7):862-9. doi: 10.1093/oxfordjournals.humrep.a137199.
Sixteen patients, 15 with primary ovarian failure and one carrier of chromosomal abnormality, received 21 embryo transfers following in-vitro fertilization of donated oocytes. Hormone replacement therapy was given to mimic a natural menstrual cycle. Five pregnancies were achieved (four infants delivered and one early pregnancy loss). All patients had endometrial biopsies taken in a preceding cycle of hormone replacement therapy. The majority (61%) showed delayed maturation compared with the expected appearances for the day of the cycle as assessed on light microscopy. Patients who conceived had a significantly better endometrial response than those who did not. Five out of seven patients (71%) conceived when the endometrium was 'in phase' (less than 2 days' delay). This suggests that endometrial receptivity is a key factor in conception. The implications for improving outcome from in-vitro fertilization treatment are discussed.
16名患者,其中15名患有原发性卵巢功能衰竭,1名是染色体异常携带者,在接受捐赠卵母细胞体外受精后进行了21次胚胎移植。给予激素替代疗法以模拟自然月经周期。成功妊娠5例(4例分娩婴儿,1例早期妊娠丢失)。所有患者均在激素替代疗法的前一周期进行了子宫内膜活检。与根据月经周期天数在光学显微镜下评估的预期外观相比,大多数(61%)显示成熟延迟。受孕患者的子宫内膜反应明显优于未受孕患者。7名患者中有5名(71%)在子宫内膜“处于相期”(延迟少于2天)时受孕。这表明子宫内膜容受性是受孕的关键因素。文中讨论了改善体外受精治疗结果的意义。